BRIEF published on 07/23/2024 at 17:57, 1 year 10 months ago GUERBET: Number of shares and voting rights as of June 30, 2024 Capital Actions AMF Guerbet Right To Vote
BRIEF published on 06/24/2024 at 12:06, 1 year 11 months ago GUERBET: Number of shares and voting rights as of May 31, 2024 Voting Rights Capital Actions AMF Guerbet
BRIEF published on 05/24/2024 at 17:50, 2 years ago Hugues Lecat Appointed Chairman of the Board of Directors at Guerbet AI Solutions Appointment Medical Imaging Hugues Lecat Guerbet Board
PRESS RELEASE published on 05/24/2024 at 17:45, 2 years ago Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet. Hugues Lecat appointed Chairman of the Board of Guerbet. Didier Izabel remains as a director. Strategic acceleration and innovative AI solutions in focus Guerbet Medical Imaging Chairman Of The Board Hugues Lecat Didier Izabel
BRIEF published on 05/21/2024 at 12:12, 2 years ago Number of Guerbet shares and voting rights as of April 30, 2024 Share Capital Voting Rights Actions Transparency Guerbet
BRIEF published on 03/20/2024 at 18:05, 2 years 2 months ago Important Changes to the Guerbet Board of Directors Board Of Directors Pharmaceutical Guerbet Medical Imaging Hugues Lecat
PRESS RELEASE published on 03/20/2024 at 18:00, 2 years 2 months ago Guerbet: Change in Guerbet’s Board of Directors. Guerbet appoints Hugues Lecat as a non-voting director with plans for him to become Chairman, enhancing the company's governance and strategic vision for future success Board Of Directors Guerbet Medical Imaging Chairman Appointment Hugues Lecat
BRIEF published on 03/20/2024 at 17:50, 2 years 2 months ago Guerbet Announces Solid Growth and Improved Profitability in 2023 Full-Year Results Financial Results Profitability Guerbet Healthcare Imaging 2023 Growth
PRESS RELEASE published on 03/20/2024 at 17:45, 2 years 2 months ago Guerbet: 2023 full-year results. Guerbet publishes solid 2023 full-year results with revenue growth of 5.9% at CER and EBITDA margin exceeding target. Confirms outlook for 2024 with revenue growth > 8% and higher profitability Revenue Growth 2024 Outlook EBITDA Margin Guerbet 2023 Full-year Results
BRIEF published on 03/11/2024 at 08:05, 2 years 3 months ago Guerbet announces key appointments to boost its long-term strategy Innovation Appointments Guerbet Medical Imaging Long-term Strategy
Published on 06/18/2026 at 15:00, 23 minutes ago Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Published on 06/18/2026 at 14:30, 53 minutes ago Voting Results from Solitario Resources Corp Annual Meeting Held June 17, 2026
Published on 06/18/2026 at 14:30, 53 minutes ago Rochon Family Executes Strategic Purchase of AIAI Holdings Shares
Published on 06/18/2026 at 14:25, 58 minutes ago Sparton Acquires Option to Past Producing Silver Property and Strengthens Board at AGM
Published on 06/18/2026 at 14:01, 1 hour 22 minutes ago Worksport (NASDAQ:WKSP) Announces $1.20 per Share Direct Investment at 100% Premium to Market; Institutional Investor Signals Interest in Up to $10 Million
Published on 06/18/2026 at 15:19, 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Forward Industries Inc.
Published on 06/18/2026 at 15:16, 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 06/18/2026 at 09:06, 6 hours 17 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 6 hours 53 minutes ago OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 8 hours 23 minutes ago bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 21 hours 43 minutes ago Report on share repurchases from 10 to 16 June 2026
